Dr. Olawaiye on How to Address Disparities in Cancer Care
Alexander B. Olawaiye, MD, discusses how to address disparities in cancer care.
Dr. Olawaiye on Front Line Treatment Sequencing Considerations in Ovarian Cancer
Alexander B. Olawaiye, MD, discusses front line treatment sequencing considerations in ovarian cancer.
Dr. Olawaiye on the Social and Biological Determinants of Disparities in Women’s Cancer
Alexander B. Olawaiye, MD, discusses the social and biological determinants of disparities in women’s cancer.
Dr. Olawaiye on Investigating Balstilimab Plus Zalifrelimab in Gynecologic Cancers
Alexander Babatunde Olawaiye, MD, discusses the investigation of balstilimab plus zalifrelimab in gynecologic cancers.
Dr. Olawaiye on the Role of Surgery in Newly Diagnosed Ovarian Cancer
Alexander B. Olawaiye, MD, discusses the role of surgery in women with newly diagnosed ovarian cancer.
Epcoritamab Plus Rituximab/Lenalidomide Produces Responses in High-risk R/R Follicular Lymphoma
TTFields Plus SOC Improves OS in Metastatic NSCLC After Progression on Platinum-based Chemotherapy
Liso-Cel Leads to Rapid Responses, High Undetectable MRD Rates in Relapsed/Refractory CLL/SLL
Datopotamab Deruxtecan Plus Pembrolizumab With or Without Chemo Produces Responses in Advanced NSCLC
2 Clarke Drive Cranbury, NJ 08512